UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Journal of the American Geriatrics Society (JAGS), 2014-04, Vol.62 (4), p.679-684

2014

Volltextzugriff (PDF)

The Montreal Cognitive Assessment-Basic: A Screening Tool for Mild Cognitive Impairment in Illiterate and Low-Educated Elderly Adults

Journal of the American Geriatrics Society (JAGS), 2015-12, Vol.63 (12), p.2550-2554

2015

Volltextzugriff (PDF)

The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

Journal of the American Geriatrics Society, 2005-04, Vol.53 (4), p.695-699

2005

Volltextzugriff (PDF)

Validation of the German Montreal-Cognitive-Assessment-H for hearing-impaired

Frontiers in aging neuroscience, 2023-07, Vol.15, p.1209385-1209385

2023

Volltextzugriff (PDF)

Evaluation of the non-auditory neurocognitive test MoCA-HI for hearing-impaired

Frontiers in neurology, 2022-12, Vol.13, p.1022292-1022292

2022

Volltextzugriff (PDF)

Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting

Dementia and geriatric cognitive disorders, 2012-01, Vol.33 (6), p.379

2012

Volltextzugriff (PDF)

MoCA Test Mandatory Training and Certification: What Is the Purpose?

Journal of the American Geriatrics Society (JAGS), 2020-02, Vol.68 (2), p.444-445

Nasreddine, Ziad S.

2020

Volltextzugriff (PDF)

MoCA Test: Validation of a five‐minute telephone version

Alzheimer's & dementia, 2021-12, Vol.17 (S8), p.e057817-n/a

Nasreddine, Ziad S

2021

Volltextzugriff (PDF)

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images

Alzheimer's & dementia : translational research & clinical interventions, 2019, Vol.5 (1), p.610-617

2019

Volltextzugriff (PDF)

Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment

Journal of the American Geriatrics Society (JAGS), 2016-12, Vol.64 (12), p.e285-e290

2016

Volltextzugriff (PDF)

Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease

Nature communications, 2019-09, Vol.10 (1), p.4227-12, Article 4227

2019

Volltextzugriff (PDF)

Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample

Neurology, 2012-03, Vol.78 (10), p.765

2012

Volltextzugriff (PDF)

Sensitivity and Specificity of the Montreal Cognitive Assessment Modified for Individuals who are Visually Impaired

Journal of visual impairment & blindness, 2010-06, Vol.104 (6), p.360-368

2010

Volltextzugriff (PDF)

Cancer‐related cognitive impairment and associated factors in a sample of older male oral‐digestive cancer survivors

Psycho-oncology (Chichester, England), 2019-07, Vol.28 (7), p.1551-1558

2019

Volltextzugriff (PDF)

The montreal cognitive assessment-basic (MoCA-B): A new mild cognitive impairment screening test for illiterate and low educated elderly

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P442-P443

2015

Volltextzugriff (PDF)

Pathogenic Implications of Mutations in the Tau Gene in Pallido-Ponto-Nigral Degeneration and Related Neurodegenerative Disorders Linked to Chromosome 17

Proceedings of the National Academy of Sciences - PNAS, 1998-10, Vol.95 (22), p.13103-13107

1998

Volltextzugriff (PDF)

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-08, Vol.330 (6), p.512

2023

Volltextzugriff (PDF)

Dementia and neurodevelopmental predisposition: Cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia

Annals of neurology, 2001-12, Vol.50 (6), p.741-746

2001

Volltextzugriff (PDF)

Proposal for Efficient Access to Cognitive Screening: using MoCA‐XpressO Pre‐screen, MoCA‐Duo Videoconference Screen, and MoCA‐Report for Post‐screen Interpretation

Alzheimer's & dementia, 2023-12, Vol.19 (S20), p.n/a

2023

Volltextzugriff (PDF)

An Automated Montreal Cognitive Assessment MoCA‐Report for Optimal Clinical Management of Alzheimer’s Disease and Initial Eligibility Assessment for Newly Approved Therapies

Alzheimer's & dementia, 2023-12, Vol.19 (S18), p.n/a

2023

Volltextzugriff (PDF)

Montreal Cognitive Assessment MoCA‐XpressO: Validation of a Digital Self‐administered Cognitive Pre‐screening Tool for the General Adult Population

Alzheimer's & dementia, 2023-12, Vol.19 (S18), p.n/a

2023

Volltextzugriff (PDF)

Evaluation of a retinal deep phenotyping platform to detect the likely cerebral amyloid PET status in humans

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(95)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease

The Montreal Cognitive Assessment-Basic: A Screening Tool for Mild Cognitive Impairment in Illiterate and Low-Educated Elderly Adults

The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

Validation of the German Montreal-Cognitive-Assessment-H for hearing-impaired

Evaluation of the non-auditory neurocognitive test MoCA-HI for hearing-impaired

Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting

MoCA Test Mandatory Training and Certification: What Is the Purpose?

MoCA Test: Validation of a five‐minute telephone version

Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images

Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment

Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease

Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample

Sensitivity and Specificity of the Montreal Cognitive Assessment Modified for Individuals who are Visually Impaired

Cancer‐related cognitive impairment and associated factors in a sample of older male oral‐digestive cancer survivors

The montreal cognitive assessment-basic (MoCA-B): A new mild cognitive impairment screening test for illiterate and low educated elderly

Pathogenic Implications of Mutations in the Tau Gene in Pallido-Ponto-Nigral Degeneration and Related Neurodegenerative Disorders Linked to Chromosome 17

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

Dementia and neurodevelopmental predisposition: Cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia

Proposal for Efficient Access to Cognitive Screening: using MoCA‐XpressO Pre‐screen, MoCA‐Duo Videoconference Screen, and MoCA‐Report for Post‐screen Interpretation

An Automated Montreal Cognitive Assessment MoCA‐Report for Optimal Clinical Management of Alzheimer’s Disease and Initial Eligibility Assessment for Newly Approved Therapies

Montreal Cognitive Assessment MoCA‐XpressO: Validation of a Digital Self‐administered Cognitive Pre‐screening Tool for the General Adult Population

A retinal deep phenotyping TM platform to predict the cerebral amyloid PET status in older adults

A retinal deep phenotypingTM platform to predict the cerebral amyloid PET status in older adults

Evaluation of a retinal deep phenotyping platform to detect the likely cerebral amyloid PET status in humans

Evaluation of a retinal deep phenotyping platform to detect the likely cerebral amyloid PET status in humans: Biomarkers (non‐neuroimaging) / novel biomarkers

Suchergebnisse filtern